Mi Recule, Inc. reported raising $1.5 Million in an amended SEC Form D filing, from an offering of $2.25 Million
Amount Raised
$1.5 Million
Round Type
Seed
Quick answer
miRecule raised $1.5 Million in a Seed round, dated November 6, 2019. miRecule is based in Gaithersburg, Maryland, United States.
- How much did miRecule raise?
- miRecule raised $1.5 Million in a Seed round on November 6, 2019.
- What does miRecule do?
- miRecule, Inc. is a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases.
- Where is miRecule based and how big is it?
- miRecule is based in Gaithersburg, Maryland, United States. Fundz records about 2 employees.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as miRecule that raised within 45 days of this round, from Fundz verified event records.
- Renovacor, Inc. raised $3.8M (Seed) on October 15, 2019.
- Windtree Therapeutics raised $26M on December 19, 2019.
- AiVita Biomedical, Inc. raised $11M on December 18, 2019.
- Grail raised $125M on December 12, 2019.
- VistaGen raised $650K on December 12, 2019.
- Apexigen raised $46M on December 11, 2019.
Who to call at miRecule, and when
A new round usually means miRecule is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day miRecule raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at miRecule, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at miRecule. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment miRecule raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
miRecule raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.